January 5, 2012
Otsuka Pharmaceutical Co., Ltd.
Mucosta® ophthalmic suspension UD2% releases on January 5, 2012
Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced the launch of Mucosta ophthalmic suspension UD 2% for patients with dry eye diagnosed on January 5, 2012 in Japan.
Information in this news release was current as of the original release date.